Atea Pharmaceuticals (AVIR) Current Leases (2021 - 2026)
Atea Pharmaceuticals (AVIR) posted quarterly Current Leases of $634000.0 for Q1 2026, down 21.82% year-over-year from $811000.0 in Q1 2025, and down 24.79% quarter-over-quarter from $843000.0 in Q4 2025.
Powered by 
Analysis
Atea Pharmaceuticals (AVIR) Current Leases (2021 - 2026) Analysis & Trends
Atea Pharmaceuticals' Current Leases history runs 6 years deep, the most recent figure standing at $634000.0 for Q1 2026.
- In Q1 2026, Current Leases fell 21.82% year-over-year to $634000.0; the TTM figure through Mar 2026 stood at $634000.0 (down 21.82% YoY), while the FY2025 annual figure was $843000.0, up 5.37% from the prior year.
- Current Leases for Q1 2026 stood at $634000.0, down from $843000.0 in the prior quarter.
- The five-year high for Current Leases was $843000.0 in Q4 2025, with the low at $113000.0 in Q1 2022.
- The 5-year median for Current Leases is $760000.0 (2023), against an average of $725588.2.
- The sharpest annual moves came in 2023 and 2026: Current Leases surged 546.02% in 2023, then fell 21.82% in 2026.
- Atea Pharmaceuticals' Current Leases stood at $721000.0 in 2022, then gained by 5.41% to $760000.0 in 2023, then gained by 5.26% to $800000.0 in 2024, then climbed by 5.38% to $843000.0 in 2025, then dropped by 24.79% to $634000.0 in 2026.
- Business Quant data shows AVIR's Current Leases at $634000.0 in Q1 2026, $843000.0 in Q4 2025, and $832000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 11.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 16.75 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 21.95 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Atea Pharmaceuticals | 467.50 Mn | 467.50 Mn | - | 424,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 424,000.00 |
| Mar 31, 2026 | 634,000.00 |
| Dec 31, 2025 | 843,000.00 |
| Sep 30, 2025 | 832,000.00 |
| Jun 30, 2025 | 821,000.00 |
| Mar 31, 2025 | 811,000.00 |
| Dec 31, 2024 | 800,000.00 |
| Sep 30, 2024 | 790,000.00 |
| Jun 30, 2024 | 780,000.00 |
| Mar 31, 2024 | 769,000.00 |
| Dec 31, 2023 | 760,000.00 |
| Sep 30, 2023 | 750,000.00 |
| Jun 30, 2023 | 740,000.00 |
| Mar 31, 2023 | 730,000.00 |
| Dec 31, 2022 | 721,000.00 |
| Sep 30, 2022 | 711,000.00 |
| Jun 30, 2022 | 730,000.00 |
| Mar 31, 2022 | 113,000.00 |
| Dec 31, 2021 | 197,000.00 |